Notification of Preliminary Results. Date: 4 May 2016

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company confirms that it will announce its Preliminary results for the year ended 31 December 2015 on Wednesday 4 May 2016.

For further information on meetings scheduled around the Preliminary results roadshow or media enquiries, please contact Lisa Baderoon on lisa.baderoon@immupharm.com